Allergy Therapeutics plc (AIM: AGY)
London
· Delayed Price · Currency is GBP · Price in GBX6.40
+0.20 (3.23%)
Dec 20, 2024, 2:00 PM GMT+1
Allergy Therapeutics Revenue
In the fiscal year ending June 30, 2024, Allergy Therapeutics had annual revenue of 55.20M GBP, down -7.36%. Allergy Therapeutics had revenue of 21.63M in the half year ending June 30, 2024, a decrease of -10.16%.
Revenue
55.20M
Revenue Growth
-7.36%
P/S Ratio
4.34
Revenue / Employee
90.19K
Employees
612
Market Cap
305.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 55.20M | -4.39M | -7.36% |
| Jun 30, 2023 | 59.59M | -13.18M | -18.11% |
| Jun 30, 2022 | 72.77M | -11.56M | -13.71% |
| Jun 30, 2021 | 84.33M | 6.13M | 7.83% |
| Jun 30, 2020 | 78.20M | 4.49M | 6.09% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAllergy Therapeutics News
- 6 months ago - Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewsWire
- 3 years ago - Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut - GlobeNewsWire
- 4 years ago - Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020 - Invezz